Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Feedback ( (GB:FDBK) ) has issued an announcement.
Feedback plc, a clinical infrastructure specialist serving healthcare providers, develops digital connectivity and collaboration tools such as its award-winning Bleepa platform to support more efficient, community-based care. Its SaaS-based model targets both public and private healthcare markets, including the NHS, with a focus on scalable, recurring revenue and enhanced clinical productivity.
The company has granted 438,148 share options to Chief Financial Officer Emma Oswick under its EMI Share Option Scheme, exercisable at 20 pence, a 105% premium to the latest closing share price. The options vest over time and are tied to ambitious revenue milestones of £8m, £12m, and £20m, aligning executive incentives with long-term growth and bringing total outstanding options to 10.2% of Feedback’s issued share capital.
Spark’s Take on FDBK Stock
According to Spark, TipRanks’ AI Analyst, FDBK is a Neutral.
The score is held down primarily by deteriorating financial performance (sharp revenue decline, very large/worsening losses, and ongoing cash burn), partially offset by a debt-free balance sheet. Technicals add modest support due to an upward trend, but extremely overbought signals raise near-term risk. Valuation provides limited support given negative earnings and no dividend yield data.
To see Spark’s full report on FDBK stock, click here.
More about Feedback
Feedback plc is a clinical infrastructure specialist that partners with health and care providers to improve productivity through digital connectivity and asynchronous collaboration. Its flagship SaaS platform, Bleepa, enables secure information sharing and more efficient patient pathways, supporting the shift from hospital-centric to community-based care across domestic and international healthcare markets, including the NHS.
The company’s scalable software model is designed to increase revenue visibility as its customer base grows, positioning Feedback as a strategic digital enabler for both public and private healthcare systems. By integrating disparate systems and uniting data and clinical teams, Feedback aims to enhance decision-making, reduce geographic barriers, and help providers meet operational targets without expanding their clinical workforce.
Average Trading Volume: 155,357
Technical Sentiment Signal: Strong Sell
Current Market Cap: £4.71M
For an in-depth examination of FDBK stock, go to TipRanks’ Overview page.